Abbreviations5MeC5‐methylcytidineAGEAdvanced glycation end productsRAGEAdvanced glycation end products receptorAMPKAMP‐activated protein kinaseBcl‐2Anti‐apoptotic proteinC1Control animals of short‐term experimentC2Control animals of long‐term experimentM1Control animals treated with MLT of short‐term experimentM2Control animals treated with MLT of short‐term experimentDMDiabetes mellitusDABDiaminobenzidineGLUT2Glucose transporter type 2GSTPIGlutathione S‐transferase piPINIntraepithelial neoplasiaLHLuteinizing hormoneMLTMelatoninMTR1Melatonin receptor type 1D1One‐week‐diabetic ratsMD1One‐week‐diabetic rats treated with MLTPCNAProliferating cell nuclear antigenPIAProliferative inflammatory atrophyPINProstate intraepithelial neoplasiaPKAProtein kinases APKBProtein kinases BPKCProtein kinases CROSReactive oxygen speciessmcSmooth muscle cellsSTZStreptozotocinD2Two‐month‐diabetic ratsMD2Two‐month‐diabetic rats treated with MLT.IntroductionThe association between diabetes mellitus (DM) and prostate cancer is controversial. Some clinical studies have associated DM, especially type‐1, with a lower risk of prostate cancer, attributed to the protective effects of insulin lack and lower testosterone levels (Moreira et al., ; Fall et al., ; Xu et al., ; Yu et al., ). This is due because insulin regulates the production of testosterone by affecting the hypothalamic‐hypophyseal‐testes axis (Kirchick et al., ) and producing local effects through insulin receptors (Bhasin et al., ; Cáp, ). Insulin‐like growth factor 1 (IGF‐1) was identified as a major regulator of epithelial cell survival in the rat ventral prostate (Ohlson et al., ). On the other hand, poor glycemic control has been associated with higher risk of prostate cancer (Ishiguro et al.,
Cell Biology International – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud